COST ends the week with an interesting split: the short retreat that has run since late June is still intact, yet borrow costs have jumped sharply off last week's near-zero floor.
The most notable development this week is how quickly the cost to borrow reversed. Two days ago, CTB sat at just 0.026% — effectively free. It has since climbed to 0.45%, a near-500% move in a week, bringing it back to levels last seen in mid-June. That said, context matters: 0.45% remains extremely cheap in absolute terms, and borrow availability is essentially unconstrained, with the lending pool holding over 340 million shares against roughly 7.75 million shorted. The jump in CTB is a data point worth watching, but it does not signal any structural tightening in the lending market. Short interest itself has continued its gradual descent — now at 7.75 million shares, or 1.75% of free float, down from the June 23 peak of around 7.96 million. The short score has drifted lower all week, from 33.0 on June 26 to 32.7 today, consistent with the slow unwind that has been underway since the May 28 earnings miss. Shorts are leaving quietly, not chasing the stock down.
Options tell a similarly calm story. The put/call ratio is running at 1.04, just below its 20-day average of 1.07 and about one standard deviation below that mean — meaning options traders are, if anything, slightly less defensive than usual. That's a notable contrast with the elevated PCR readings from late May and early June, when the ratio was regularly above 1.10. The market is not hedging aggressively into the next earnings event, which is scheduled for September 24.
The Street remains constructive but divided on valuation. Bulls — led by UBS and BofA, which both lifted targets in late May — see a path to $1,200–$1,275, roughly 30% above the current $947.50. The bear camp, represented by DA Davidson and Truist at $1,000–$1,011, is more cautious on tariff headwinds and margin risk. Citigroup reinstated coverage on June 18 with a Neutral and a $1,020 target, landing firmly in the skeptical middle. The mean target of $1,081 implies about 14% upside from current levels. Valuation remains stretched — the P/E is running near 44x and price-to-book above 11x, both down modestly over the past month but still well above historical norms. The factor score picture is mixed: dividend quality ranks in the 83rd percentile, but forward EPS estimate momentum is weak at the 27th percentile, and momentum deterioration has been a recurring theme in recent score notes.
On the ownership side, nothing dramatic is happening. BlackRock added roughly 556,000 shares through June 30, nudging its stake to 7.88% of outstanding. State Street added 217,000 over the same period. These are passive-flow additions, not active conviction buys. Insider activity remains one-directional — every recent trade on record is a sale, including a director sell near $957 on June 23. None of the insider transactions is large enough to move the needle, but the absence of any buying at these levels is worth noting given that the stock is trading below where several insiders sold earlier in the year.
Among peers, KR and ACI were the week's standouts, each rising nearly 5%, while WMT and BJ slipped 2-3%. COST's 1.3% gain sits in the middle of the group — neither the defensive laggard nor the momentum leader. The September 24 earnings date is the next hard catalyst, and between now and then, monthly sales data releases and any further macro news on tariffs will be the variables most likely to shift the positioning picture.
See the live data behind this article on ORTEX.
Open COST on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
COST fell nearly 8% in the week after earnings. Now two of the three signals that fired during the selloff are reversing fast. The cost to borrow has plunged 57% in one week to just 0.16% annualised — the lowest level…
COST enters the week of its next earnings date with a striking reversal in options sentiment — and the question is whether that shift reflects genuine re-rating or simply relief after last week's post-earnings…
